Health In Tech (NASDAQ:HIT) and Schrodinger (NASDAQ:SDGR) Critical Comparison

Health In Tech (NASDAQ:HIT) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation.

Insider & Institutional Ownership

79.0% of Schrodinger shares are held by institutional investors. 71.0% of Health In Tech shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations and price targets for Health In Tech and Schrodinger, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Schrodinger	1	3	4	0	2.38

Health In Tech currently has a consensus target price of $3.50, suggesting a potential upside of 489.52%. Schrodinger has a consensus target price of $26.67, suggesting a potential downside of 17.72%. Given Health In Tech’s stronger consensus rating and higher possible upside, research analysts plainly believe Health In Tech is more favorable than Schrodinger.

Profitability

This table compares Health In Tech and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Schrodinger	-22.02%	-18.12%	-9.07%

Valuation & Earnings

This table compares Health In Tech and Schrodinger”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83 million	1.19	-$4.59 million	($0.07)	-8.48
Schrodinger	$255.87 million	9.35	-$103.26 million	($0.79)	-41.03

Health In Tech has higher earnings, but lower revenue than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Health In Tech has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500.

Summary

Health In Tech beats Schrodinger on 11 of the 15 factors compared between the two stocks.

About Health In Tech

Health In Tech, Inc. is a U.S.-based insurance technology company that provides a digital platform for the self-funded health benefits market. Its technology is designed to connect employers, insurance brokers, third-party administrators and stop-loss carriers through a streamlined process for evaluating and administering health benefit plans. The company’s platform supports functions including plan quoting, comparison and enrollment, with the goal of simplifying interactions among participants in the employer-sponsored health insurance ecosystem.

About Schrodinger

Schrödinger, Inc. develops computational software used to support drug discovery and materials research. Its platform applies physics-based modeling, computational chemistry and machine learning to help researchers analyze molecular properties and identify promising candidates. The company’s tools are used by pharmaceutical and biotechnology companies, academic institutions and other research organizations. Alongside software sales and subscriptions, Schrödinger works with partners on drug discovery programs and advances a portfolio of its own therapeutic candidates.